nerve growth factor (NGF)
Showing 1 - 25 of >10,000
Nerve Growth Factor Expression in Pediatric Severe Burns:Pilot
Completed
- Burns
- pediatric patients affected by severe burns
-
Rome, ItalyGiorgio Conti
Mar 1, 2023
Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)
Not yet recruiting
- Optic Pathway Glioma
- CHF6467
- Placebo
-
Rome, ItalyCatholic University, Policlinico A. Gemelli (Hospital)
Feb 17, 2023
Ischemic Stroke Trial in Hangzhou (nerve growth factor, physiological saline, EA)
Recruiting
- Ischemic Stroke
- nerve growth factor
- +3 more
-
Hangzhou, Zhejiang, ChinaThe Third Affiliated Hospital of Zhejiang Chinese Medical Univer
Dec 14, 2022
Corneal Disease, Neuropathy Trial in Boston (Cenegermin-Bkbj)
Withdrawn
- Corneal Disease
- Neuropathy
-
Boston, MassachusettsTufts Medical Center
Jan 18, 2023
Ischemic Stroke Trial in Hangzhou (Nerver growth factor (NGF) injection, Placebo injection, EA intervention)
Recruiting
- Ischemic Stroke
- Nerver growth factor (NGF) injection
- +3 more
-
Hangzhou, Zhejiang, ChinaThe Third Affiliated Hospital of Zhejiang Chinese Medical Univer
Jul 26, 2022
Brain-derived Neurotrophic Factor Single Nucleotide Gene
Recruiting
- Allergic Rhinitis
- Genotyping.
-
Sohag, EgyptSohag university Hospital
Jun 15, 2023
New Daily Persistent Headache Biomarkers Study
Terminated
- New Daily Persistent Headache
- New Daily Persistent Headache (NDPH)
-
Bronx, New YorkMontefiore Headache Center
Feb 15, 2022
Mixed Urinary Incontinence Trial in Bucheon, Seoul (Midurethral slings (MUS))
Completed
- Mixed Urinary Incontinence
- Midurethral slings (MUS)
-
Bucheon, Korea, Republic of
- +1 more
Nov 28, 2019
Acute Ischemic Stroke Trial in Nanjing (Nerve Growth Factors, normal saline)
Completed
- Acute Ischemic Stroke
- Nerve Growth Factors
- normal saline
-
Nanjing, Jiangsu, ChinaDepartment of Neurology, Jinling Hospital
Aug 29, 2021
Breast Cancer Trial in Damanhur (Placebo, Fenofibrate 160mg)
Recruiting
- Breast Cancer
- Placebo
- Fenofibrate 160mg
-
Damanhūr, Elbehairah, EgyptDamanhour Oncology Center
Apr 1, 2023
Dry Eye Syndrome Trial in Wien (rhNGF 20 µg/mL, rhNGF 4 µg/mL)
Completed
- Dry Eye Syndrome
- rhNGF 20 µg/mL
- rhNGF 4 µg/mL
-
Wien, AustriaDepartment of Clinical Pharmacology
Dec 14, 2022
Overactive Bladder Trial in Seoul (Oxybutinin, Fesoterodine, Solifenacin, Propiverin, Trospium)
Completed
- Overactive Bladder
- Oxybutinin, Fesoterodine, Solifenacin, Propiverin, Trospium
-
Seoul, Korea, Republic ofSamsung Medical Center
Nov 28, 2019
Micronerves in Dupuytren and Impact of Its Dissection on
Not yet recruiting
- Dupuytren's Disease
- Microfasciectomy
-
Leuven, Vlaams-Brabant, BelgiumUniversitaire Ziekenhuizen KU Leuven
Nov 15, 2023
Benign Prostatic Hypertrophy With Outflow Obstruction, Overactive Detrusor Trial in Seoul (Holmium Laser Enucleation of the
Completed
- Benign Prostatic Hypertrophy With Outflow Obstruction
- Overactive Detrusor
- Holmium Laser Enucleation of the Prostate (HoLEP)
- Holmium laser enucleation system and morcellator
-
Seoul, Korea, Republic ofSamsung Medical Center
Nov 28, 2019
Symptoms of Overactive Bladder and Pelvic Organ Prolapse
Recruiting
- Overactive Bladder
- Urinary Nerve Growth Factor
-
Thessaloníki, Central Macedonia, GreeceAristotle University of Thessaloniki
Dec 1, 2021
Healthy Volunteers Trial in Chengdu (EP-9001A, )
Recruiting
- Healthy Volunteers
- EP-9001A
- placebo
-
Chengdu, Sichuan, ChinaWest China Hospital,Sichuan University
Mar 30, 2022
Injury of Optic Nerve Trial in Beijing (Recombinant human nerve growth factor injection,experimental, Recombinant human nerve
Recruiting
- Injury of Optic Nerve
- Recombinant human nerve growth factor injection,experimental
- +2 more
-
Beijing, Beijing, ChinaBeijing Tongren Hospital
Aug 10, 2021
Validation of a Novel Cortical Biomarker Signature for Pain
Recruiting
- TMD
- Injection of Nerve Growth Factor
-
Baltimore, Maryland
- +1 more
Jul 11, 2022
Temporomandibular Joint Disorders Trial in Alexandria (Nd-YAG Fotona, Epidermal Growth Factor)
Enrolling by invitation
- Temporomandibular Joint Disorders
- Nd-YAG Fotona
- Epidermal Growth Factor
-
Alexandria, الإسكندرية, EgyptAlexandria University
Sep 13, 2023
Nerve Growth Factor for the Treatment of Cornea Disease
Completed
- Neurotrophic Keratitis
-
Stanford, CaliforniaStanford University
Dec 10, 2021
Organ Protection Trial (Lidocaine, Normal saline (NS))
Not yet recruiting
- Organ Protection
- Lidocaine
- Normal saline (NS)
- (no location specified)
Aug 13, 2022
HIV, Peripheral Nervous System Disease Trial in United States (Nerve Growth Factor, Recombinant Human)
Completed
- HIV Infections
- Peripheral Nervous System Disease
- Nerve Growth Factor, Recombinant Human
-
Los Angeles, California
- +13 more
Oct 27, 2021
Type II Diabetes With Neurological Manifestations Trial (Phsical Activity, Medication)
Not yet recruiting
- Type II Diabetes Mellitus With Neurological Manifestations
- Phsical Activity
- Medication
- (no location specified)
Oct 20, 2023
Alcohol-induced Brain Injury Trial in Guangzhou (Nerve Growth Factor, Edaravone, Combination of vitamin B1, B6, C, E and
Unknown status
- Alcohol-induced Brain Injury
- Nerve Growth Factor
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Oct 24, 2020
Peripheral Neuropathy Due to Chemo Trial in Cairo (Losartan)
Recruiting
- Peripheral Neuropathy Due to Chemotherapy
-
Cairo, EgyptBreast Cancer Comprehensive Center of the National Cancer Instit
Nov 26, 2023